$2.08
-0.03-1.42%
After Hours: Sep 17, 8:50 AM EDT
15 minutes delayed
Comments
Loading...
Cellectar Biosciences (CLRB) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestCellectar Biosciences (NASDAQ:CLRB) Stock Quotes, Forecast and News Summary
Cellectar Biosciences Stock (NASDAQ: CLRB) stock price, news, charts, stock research, profile.
| Open | $2.14 |
| Close | - |
| Volume / Avg. | 254.80K / 567.80K |
| Day Range | $2.09 - $2.21 |
| 52 Wk Range | 1.82 - 4.45 |
| Market Cap | $75.46M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 47 |
| Short Interest | 8.13% |
| Days to Cover | 10.52 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Cellectar Biosciences Inc
Sector
Health Care
Industry
Biotechnology
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discov...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry